MedPath

To assess the combined effect of Shirodhara, Kalyanaka ghrta and Satvavajaya Chikitsa {Counselling} in Social Anxiety Disorder.

Phase 2/3
Not yet recruiting
Conditions
Other specified anxiety disorders,
Registration Number
CTRI/2019/05/019140
Lead Sponsor
Amrita School of Ayurveda
Brief Summary

**Background:** Social Anxiety disorder [SAD] is a prevalent anxiety disorder characterized by significant amount of fear in one or more social situations which is persistent, typically lasting for 6 months or more. According to DSM 5, its prevalent rate decreases with age, more in adolescents than in young adults. In general, higher rates of social anxiety disorder is found in females than in males in the general population. The 12 month prevalence for older adults ranges from 2% to 5%. The present day management of Social Anxiety Disorder involves usage of anxiolytics and their use is limited owing to the risk of drug abuse and dependence.

Ayurveda is a science of life and gives equal significance to physical, mental, social and spiritual health. In the life time, one may suffer from physical, mental and spiritual ailments of which the Acharya’s have elaborately mentioned in classical texts (Samhitas). Based on the symptoms of SAD, there are similar references in Bhagavat Gita and Visadhata lakshana from Ashtangahrdaya. It refers to the Udvega Avastha of Manas (excited state of mind) which is caused by vitiated Rajas and having the predominance of Vata and Pitta Dosha.

Shirodhara is considered the best therapy for diseases pertaining to the head, eye and ear, gives good sleep and which helps in relieving stress and Vata Vrddhi symptoms and that of Social Anxiety Disorder. Kalyanaka Ghritha mentioned in Charaka Samhitha, Unmada Chikitsa, is having Medhya property so it is selected as the Samanoushada for Social Anxiety Disorder. Satvavajaya Chikitsa provides Dhi, Dhairya, Atma jnana and Asvasana to the patient. This study aims to explore safe, effective and economical management of SAD following the therapeutic principles of Ayurveda.

**Objective:**  To find out the combined effect of Shirodhara, Kalyanaka ghritha and Satvavajaya Chikitsa in reducing the symptoms of Social Anxiety Disorder using DSM-5 Assessment Scale.

Study Design: It will be a single group clinical study with pre and post-test study Design. 20 Patients who fulfil the inclusion criteria will be taken. Patient will be evaluated according to Diagnostic and Statistical Manual of Mental Disorders Assessment Criteria and the following treatment will be given.

**Method:**Pacana Deepana will be administered on OP basis with Vaishwanara Choorna (12gm) in a divided dosage with hot water and Gandharvahastadi Kashaya (48 ml dosage) with a pinch of saindhava (Rock salt) and jaggery before food twice daily for 1-7 days. Then patient will be admitted to the ward and Shirodhara will be administered with Balaguduchyadi Taila (8th- 14th day). Simultaneously Satvavajaya chikitsa (8th -14th day) and Kalyanaka Ghritha (48 ml) in a divided dosage before food as Samanoushada for (8th -30th day).

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients fulfilling the diagnostic criteria for Social Anxiety Disorder as per DSM 5 Diagnostic criteria.
  • Age between 20 to 60 years.
  • Patients with either gender irrespective of socioeconomic status Patients willing to join the study and sign the informed consent form.
Exclusion Criteria
  • Patients with other psychiatric disorders Pregnant women, Lactating mothers and children.
  • Patients with metabolic disorders and other systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DSM 5 Assessment Criteria30 days
Secondary Outcome Measures
NameTimeMethod
DSM 5 Assessment Criteria30 days

Trial Locations

Locations (1)

Amrita School of Ayurveda

🇮🇳

Kollam, KERALA, India

Amrita School of Ayurveda
🇮🇳Kollam, KERALA, India
Dr Neeraja M A
Principal investigator
8606404661
niaaa8053@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.